Trial Profile
Open-label evaluation of the efficacy and safety of etanercept in patients with active rheumatoid arthritis (RA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2007
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Wyeth
- 30 Oct 2007 New trial record.